SecBot SecBot

STIM

Neuronetics, Inc.
Nasdaq· Surgical & Medical Instruments & Apparatus· Inc. DE· CIK 0001227636 Healthcare & Medical Devices
$2.24 +0.13 (+6.16%)
Oct 26 4:00 PM ET · prev $2.11
Market cap
$158.5M
Micro cap
Consensus
Buy
90% Buy or better · 10 analysts
Median target
$5.50
+146% · range $5.00–7.00
Next earnings
Nov 4
in 8 days · EPS est. −$0.11
1 year
−27.5%
from $3.09 · Oct 27
30 days
−12.3%
from $2.56
52-week range
$1.18–3.30
−32% from high · low May 18
Avg volume 20D
766.0K
shares / day
Short interest
🔒 Subscribers only
Insider net
+$4.6M
1 buyer · 4 sellers · 12 mo
New fund stakes
0
Q2 2026 13F · 0 exits
Filing reports
15
analyzed by SecBot
SecBot read BULLISH 2 reports · 90 days
Balance 0 bearish · 2 bullish oldest → newest, height = score
Avg score ·High conf. 2/2 ·Next Earnings date, Nov 4, 2026

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

  • S Feb 26 to Mar 4 2 days of insider sells: $16.9K by 2 insiders, avg $1.35
  • B Mar 17 to Mar 30 8 days of insider buys: $3.6M by 1 insider, avg $1.30
  • B Apr 20 to Apr 21 2 days of insider buys: $309.0K by 1 insider, avg $1.55
  • B May 12 to May 19 2 days of insider buys: $753.5K by 1 insider, avg $1.31
  • R Aug 11 Neuronetics reported Q2 2026 revenue of $41.6M (+9.1% YoY), beating…
  • S Aug 13 1 insider sell $321.00 at $3.21
  • B Aug 14 1 insider buy $44.2K at $3.16
  • A Sep 11 B. Riley Securities initiates

Signal stack

Where each data set points today.

  • InsidersBULLISH

    1 insider bought $4.8M at an average $1.33. 4 insiders sold $203.1K. Price is 68% above their cost.

  • InstitutionsBEARISH

    Q2 2026: 10 added (0 new), 15 trimmed or exited.

  • AnalystsBULLISH

    9 of 10 rate it Buy or better. Every target is above the price.

  • EstimatesRISING

    Current-quarter EPS estimate −$0.113 → −$0.110 over 90 days. 2 up, 0 down in 30 days.

  • TrendDOWNTREND

    14% below its 50-day average.

Who's buying

13F· Q2 2026
0
new positions
0
exits
FundMoveSharesValue
VANGUARD CAPITAL MANAGEMENT LLCTRIM1,507,097$2.0M
BlackRock, Inc.TRIM596,622$775.6K
GEODE CAPITAL MANAGEMENT, LLCTRIM458,474$596.2K
CITADEL ADVISORS LLCDOUBLED421,903$548.5K
STATE STREET CORPTRIM290,299$377.4K
Centiva Capital, LPADD285,913$371.7K
SUSQUEHANNA INTERNATIONAL GROUP, LLPDOUBLED185,753$241.5K
JANE STREET GROUP, LLCDOUBLED185,250$240.8K

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

10 analysts
Buy 90% rate it Buy or better
Strong Buy3Buy6Hold1Sell0Strong Sell0
12-month targets · 4 analysts

Price is below the lowest target. Median implies +146%.Targets as of Oct 27, 2026.

Recent actions
DateFirmActionRating
Sep 17, 2026BTIG
REITERATE
REITERATEBuy
Sep 11, 2026B. Riley Securities
INITIATE
INITIATEBuy
Sep 9, 2026BTIG
REITERATE
REITERATEBuy
Aug 11, 2026BTIG
MAINTAIN
MAINTAINBuy
Jul 20, 2026BTIG
INITIATE
INITIATEBuy

Insider ledger

Form 4
$4.8M
bought · 1 insider
$203.1K
sold · 4 insiders
+68.4%
vs their $1.33 cost
DateInsiderTypeValue
Aug 14, 2026
Chernett Jorey
10%+ Owner
BUY$44.2K
Aug 13, 2026
Chernett Jorey
10%+ Owner
SELL$321.00
Jul 23, 2026
Naor Nir
EVP, CFO & Treasurer
AWARD500,000 sh
Jul 14, 2026
Chernett Jorey
10%+ Owner
BUY$62.3K
Jun 15, 2026
Madryn Asset Management, LP
10%+ Owner
OTHER2,934 sh
Jun 15, 2026
Amin Avinash
Director
OTHER2,934 sh
Jun 15, 2026
Amin Avinash
Director
OTHER34,932 sh
Jun 15, 2026
Amin Avinash
Director
OTHER4,634 sh

Earnings setup

Estimates
Nov 4
reports in 8 days
−$0.11
EPS estimate, this quarter
+3%
estimate change, 90 days
2↑ 0↓
revisions, 30 days
Current-quarter EPS estimate
PeriodEPS est.Range30D rev.Revenue
Current Q-$0.11-$0.11–-$0.11+2.9%$40.4M
Next Q-$0.07-$0.07–-$0.07+4.5%$45.6M
Current FY🔒 Fresh data, subscribers only
Next FY-$0.34-$0.34–-$0.34-1.0%$177.0M

Washington

Q3 2026
Lobbying Q3 None no reports
YoY n/a vs Q3 2025
Members 0 all time
Buys / sells 0 / 0 0 trades

Short side

FINRA· Oct 15, 2026
🔒 Subscribers only
shares short
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Aug 14, 2026 Insider
Chernett Jorey bought 14,000 shares
10%+ Owner @ $3.16 ($44.2K)
Aug 13, 2026 Insider
Chernett Jorey sold 100 shares
10%+ Owner @ $3.21 ($321.00)
Aug 11, 2026 SEC
Neuronetics reported Q2 2026 revenue of $41.6M (+9.1% YoY), beating the $40.2M consensus, and EPS of -$0.05, a 59.2%…
8-K — Impact 6/10
Aug 11, 2026 SEC
Neuronetics reported Q2 2026 revenue of $41.6M (+9.1% YoY), beating the $40.2M consensus, and EPS of -$0.05, a 59.2%…
PRESS-RELEASE — Impact 6/10
Aug 11, 2026 Earnings
Neuronetics Reports Second Quarter 2026 Financial and Operating Results
MALVERN, Pa., Aug. 11, 2026 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM) (the “Company” or “
Jul 23, 2026 Insider
Naor Nir was granted 500,000 shares
EVP, CFO & Treasurer
Jun 30, 2026 Inst.
VANGUARD CAPITAL MANAGEMENT LLC — TRIM
1,507,097 shares ($2.0M)
Jun 30, 2026 Inst.
BlackRock, Inc. — TRIM
596,622 shares ($775.6K)
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Upcoming
Recent

SecBot reports

15 filings · 2 press releases · 4 bullish · 2 bearish · 1 mixed · 8 neutral
All STIM filing & press-release reports (17)